Allspring Global Investments’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-39,352
| Closed | -$591K | – | 1628 |
|
|
2025
Q1 | $591K | Sell |
39,352
-2,922
| -7% | -$43.9K | ﹤0.01% | 1399 |
|
|
2024
Q4 | $696K | Sell |
42,274
-25,528
| -38% | -$420K | ﹤0.01% | 1374 |
|
|
2024
Q3 | $1.67M | Buy |
67,802
+9,440
| +16% | +$233K | ﹤0.01% | 1207 |
|
|
2024
Q2 | $1.48M | Sell |
58,362
-6,908
| -11% | -$175K | ﹤0.01% | 1245 |
|
|
2024
Q1 | $1.66M | Buy |
65,270
+14,259
| +28% | +$362K | ﹤0.01% | 1244 |
|
|
2023
Q4 | $1.16M | Sell |
51,011
-4,201
| -8% | -$95.2K | ﹤0.01% | 1302 |
|
|
2023
Q3 | $1.03M | Sell |
55,212
-20,619
| -27% | -$384K | ﹤0.01% | 1355 |
|
|
2023
Q2 | $1.97M | Buy |
75,831
+26,268
| +53% | +$682K | ﹤0.01% | 1239 |
|
|
2023
Q1 | $1.42M | Buy |
49,563
+906
| +2% | +$26K | ﹤0.01% | 1338 |
|
|
2022
Q4 | $1.44M | Sell |
48,657
-26,080
| -35% | -$772K | ﹤0.01% | 1336 |
|
|
2022
Q3 | $1.78M | Buy |
74,737
+1,198
| +2% | +$28.5K | ﹤0.01% | 1268 |
|
|
2022
Q2 | $1.64M | Buy |
73,539
+55,679
| +312% | +$1.24M | ﹤0.01% | 1294 |
|
|
2022
Q1 | $448K | Buy |
17,860
+2,644
| +17% | +$66.3K | ﹤0.01% | 2274 |
|
|
2021
Q4 | $545K | Buy |
+15,216
| New | +$545K | ﹤0.01% | 2251 |
|